Colon adenocarcinoma is one of the most common cancers worldwide, and resistance to current 19 therapeutic modalities is a serious drawback in its treatment. Auraptene is a natural coumarin with 20 considerable anticancer effects. The goal of present study was to introduce a novel combinatorial 21 approach against colon adenocarcinoma cells. To do so, HT29 cells were pretreated with non-toxic 22 auraptene and then hyperthermia was applied. Afterwards, viability of cells was assessed, changes 23 induced in the cell cycle were analyzed, and expression pattern of candidate genes was studied. 24
To overcome limitations of conventional therapies, great deal of investigation has focused on 42 designation of novel and combined strategies, for instance, concomitant use of hyperthermia with 43 chemical drugs and/or ionizing radiation (Kolosnjaj-Tabi and Wilhelm, 2017) . Thermal ablation of 44 tumors is a rapidly developing approach that preserves surrounding tissues by intra-procedural 45 monitoring. However, incomplete ablation, disease recurrence and inferior outcomes are draw backs 46 that decrease hyperthermia efficacy (Chu and Dupuy, 2014) . 47 D r a f t
Preparation of auraptene 69
Auraptene [7-((E)-3, 7Dimethylocta-2,6-dienyloxy)-2H-chromen-2one] was synthesized based on a 70 previously described method (Askari et al. 2009 ). In summary, 7-hydroxy-coumarin (1 M) and trans-71 geranyl bromide (1.5 M) were reacted in acetone at room temperature, in the presence of 1,8-72 diazabicyclo[5.4.0]undec-7-ene (DBU) (2M). Then, auraptene was purified as white crystals (mp = 73 62.7-63.4 ‫؛‬C) by column chromatography using petroleum ether/ethyl acetate (9:1, v/v), and its 74 structure was confirmed by 1 H-and 13 C-nuclear magnetic resonance. 75
To prepare different concentrations of auraptene, 2 mg of the crystal was dissolved in 100 µl 76 dimethylsulfoxide (DMSO, Merck) and diluted with complete culture medium. To note, equal amount 77
of DMSO in all auraptene concentrations (0.4% v/v) was considered as control treatment. 78
Culture and treatment of cells 79
HT29 cells were obtained from Pasteur Institute (Tehran, Iran) and cultured in Roswell park memorial 80 institute (RPMI) 1640 (Biowest) supplemented with 10% fetal bovine serum (FBS, Biowest) and 1% 81 (W/V) penicillin/streptomycin (Biowest). Cells were incubated at 37°C in a humidified atmosphere of 82 5% CO 2 in air, and subcultured using 0.25 % trypsin-1 mM EDTA (Biowest). 83
To investigate toxic effects of hyperthermia in combination with auraptene, HT29 cells were 84 pretreated with 10 and 20 µg/ml auraptene, as well as relevant DMSO control, for 24, 48 and 72 h, 85
and then heat shock was applied by transferring cell culture plates into a water bath for 30 min at 86 51°C, followed by 12 and 24 h recovery in CO 2 incubator at 37°C. 87
Cell viability assay 88
To assess viability of cells upon combinatorial treatment with auraptene and hyperthermia, 89 
Cell cycle analysis 96
To determine changes induced in the cell cycle after combinatorial treatment, HT29 cells were stained 97
with propidium iodide (PI, Sigma). Briefly, floating and attached cells in each treatment were 98 collected and washed with cold PBS containing 5% FBS. Then, cell pellets were resuspended in a 99
hypotonic buffer containing 50 µg/ml PI in 0.1% sodium citrate and 0.1% Triton X-100, incubated for 100
15 min at 4 °C in the dark, and flow cytometrically analyzed using a FACSCalibur instrument (BD 101
Biosciences). 102

Gene expression studies 103
To investigate effects of auraptene and hyperthermia on the expression of apoptosis and heat shock 104 mediators, real-time RT-PCR was applied. In this regard, the total cellular RNA was extracted from 105 treated cells and their relevant controls using RNX-plus (Cinnagen). After RNA samples were treated 106
with DNase I (Thermo Scientific), cDNAs were synthesized using oligo-dT, dNTPs and M-MuLV 107 reverse transcriptase (Thermo Scientific) according to the manufacturer's protocol. Colon adenocarcinoma is one of the most common cancers worldwide with high mortality rate. 153
Recurrence of colon cancer is common among patients, and developed resistance to current 154 Rashmi et al. 2003; Tabuchi et al. 2008; Schafer et al. 2012) . In line with our 207
findings, increased thermally-induced apoptosis in melanoma and colon cancer cells has been reported 208 upon HSP27 knock down (Wang et al. 2016; Chen et al. 2007) . Accordingly, it is presumable that 209 improved toxicity of hyperthermia in auraptene pretreated cells might also be due to slight down 210 regulation of HSP27 in HT29 cells. 211
In conclusion, present attempt provided evidence, for the first time, on improved efficacy of 212 hyperthermia by auraptene in colon adenocarcinoma cells. 
